[Alcoholism and depression: catecholamines and brain-derived neurotrophic factors].

R. Yoshimura,W. Nakano,Kiyoshi Nakamura

Abstract:

What problem does this paper attempt to address?

Role of solute carrier transporters in regulating dendritic cell maturation and function

Lin Shao,Mengxin Yang,Tao Sun,Haotang Xia,Dan Du,Xun Li,Zuliang Jie

DOI: https://doi.org/10.1002/eji.202350385

2023-12-12

European Journal of Immunology

Abstract:Dendritic cells (DCs) are specialized antigen‐presenting cells (APCs) that initiate and regulate innate and adaptive immune responses. Solute carrier (SLC) transporters mediate diverse physiological functions and maintain cellular metabolite homeostasis. Recent studies have highlighted the significance of SLCs in immune processes. Notably, upon activation, immune cells undergo rapid and robust metabolic reprogramming, largely dependent on SLCs to modulate diverse immunological responses. In this review, we explore the central roles of SLC proteins and their transported substrates in shaping DC functions. We provide a comprehensive overview of recent studies on amino acid transporters, metal ion transporters, and glucose transporters, emphasizing their essential contributions to DC homeostasis under varying pathological conditions. Finally, we propose potential strategies for targeting SLCs in DCs to bolster immunotherapy for a spectrum of human diseases. This article is protected by copyright. All rights reserved

immunology
The Role of Glutathione in the Management of Cell-Mediated Immune Responses in Individuals with HIV

Nicole Lin,Thomas Erdos,Carson Louie,Raina Desai,Naomi Lin,Gregory Ayzenberg,Vishwanath Venketaraman

DOI: https://doi.org/10.3390/ijms25052952

IF: 5.6

2024-03-04

International Journal of Molecular Sciences

Abstract:Human immunodeficiency virus (HIV) is a major cause of death worldwide. Without appropriate antiretroviral therapy, the infection can develop into acquired immunodeficiency syndrome (AIDS). AIDS leads to the dysregulation of cell-mediated immunity resulting in increased susceptibility to opportunistic infections and excessive amounts of inflammatory cytokines. HIV-positive individuals also demonstrate diminished glutathione (GSH) levels which allows for increased viral replication and increased pro-inflammatory cytokine release, further contributing to the high rates of mortality seen in patients with HIV. Adequate GSH supplementation has reduced inflammation and slowed the decline of CD4+ T cell counts in HIV-positive individuals. We aim to review the current literature regarding the role of GSH in cell-mediated immune responses in individuals with HIV- and AIDS-defining illnesses.

biochemistry & molecular biology,chemistry, multidisciplinary
Glutathione synthesis is compromised in erythrocytes from individuals with HIV

Devin Morris,Judy Ly,Po-Ting Chi,John Daliva,Truongson Nguyen,Charleen Soofer,Yung C. Chen,Minette Lagman,Vishwanath Venketaraman

DOI: https://doi.org/10.3389/fphar.2014.00073

IF: 5.6

2014-04-11

Frontiers in Pharmacology

Abstract:We demonstrated that the levels of enzymes responsible for the synthesis of glutathione (GSH) such as glutathione synthase (GSS), glutamate-cysteine ligase-catalytic subunit (GCLC), and glutathione reductase (GSR) were significantly reduced in the red blood cells (RBCs) isolated from individuals with human immunodeficiency virus (HIV) infection and this reduction correlated with decreased levels of intracellular GSH. GSH content in RBCs can be used as a marker for increased overall oxidative stress and immune dysfunctions caused by HIV infection. Our data supports our hypothesis that compromised levels of GSH in HIV infected individuals' is due to decreased levels of GSH-synthetic enzymes. The role of GSH in combating oxidative stress and improving the functions of immune cells in HIV patients' indicates the benefit of an antioxidant supplement which can reduce the cellular damage and promote the functions of immune cells.

pharmacology & pharmacy
Host genetics contributes to the effectiveness of dendritic cell-based HIV immunotherapy

Edione C. Reis,Lais T. da Silva,Wanessa C. da Silva,Alexandre Rios,Alberto J. Duarte,Telma M. Oshiro,Sergio Crovella,Alessandra Pontillo

DOI: https://doi.org/10.1080/21645515.2018.1463942

2018-05-17

Abstract:Systems biological analysis has recently revealed how innate immune variants as well as gut microbiota impact the individual response to immunization. HIV-infected (HIV+) patients have a worse response rate after standard vaccinations, possibly due to the immune exhaustion, increased gut permeability and microbial translocation. In the last decade, dendritic cells (DC)-based immunotherapy has been proposed as an alternative approach to control HIV plasma viral load, however clinical trials showed a heterogeneity of immunization response. Hypothesizing that host genetics may importantly affects the outcome of immunotherapy in HIV+ patients, genetic polymorphisms' distribution and gene expression modulation were analyzed in a phase I/II clinical trial of DC-based immunotherapy according to immunization response, and quality of vaccine product (DC). Polymorphisms in genes previously associated with progression of HIV infection to AIDS (i.e.: PARD3B, CCL5) contribute to a better response to immunotherapy in HIV+ individuals, possibly through a systemic effect on host immune system, but also directly on vaccine product. Genes expression profile after immunization correlates with different degrees of immune chronic activation/exhaustion of HIV+ patients (i.e. PD1, IL7RA, EOMES), but also with anti-viral response and DC quality (i.e.: APOBEC3G, IL8, PPIA), suggested that an immunocompetent individual would have a better vaccine response. These findings showed once more that host genetics can affect the response to DC-based immunotherapy in HIV+ individuals, contributing to the heterogeneity of response observed in concluded trials; and it can be used as predictor of immunization success.

immunology,biotechnology & applied microbiology
Cystine/Glutamate Antiporter in Schizophrenia: From Molecular Mechanism to Novel Biomarker and Treatment

Chung-Chieh Hung,Chieh-Hsin Lin,Hsien-Yuan Lane

DOI: https://doi.org/10.3390/ijms22189718

IF: 5.6

2021-09-08

International Journal of Molecular Sciences

Abstract:Glutamate, a crucial excitatory neurotransmitter, plays a major role in the modulation of schizophrenia’s pathogenesis. New drug developments for schizophrenia have been prompted by the hypoglutamatergic hypothesis of schizophrenia. The cystine/glutamate antiporter system xc− is related to glutamate-release regulation. Patients with schizophrenia were recently discovered to exhibit downregulation of xc− subunits—the solute carrier (SLC) family 3 member 2 and the SLC family 7 member 11. We searched for relevant studies from 1980, when Bannai and Kitamura first identified the protein subunit system xc− in lung fibroblasts, with the aim of compiling the biological, functional, and pharmacological characteristics of antiporter xc−, which consists of several subunits. Some of them can significantly stimulate the human brain through the glutamate pathway. Initially, extracellular cysteine activates neuronal xc−, causing glutamate efflux. Next, excitatory amino acid transporters enhance the unidirectional transportation of glutamate and sodium. These two biochemical pathways are also crucial to the production of glutathione, a protective agent for neural and glial cells and astrocytes. Investigation of the expression of system xc− genes in the peripheral white blood cells of patients with schizophrenia can facilitate better understanding of the mental disorder and future development of novel biomarkers and treatments for schizophrenia. In addition, the findings further support the hypoglutamatergic hypothesis of schizophrenia.

biochemistry & molecular biology,chemistry, multidisciplinary
SLC38A2 and glutamine signalling in cDC1s dictate anti-tumour immunity

Chuansheng Guo,Zhiyuan You,Hao Shi,Yu Sun,Xingrong Du,Gustavo Palacios,Cliff Guy,Sujing Yuan,Nicole M. Chapman,Seon Ah Lim,Xiang Sun,Jordy Saravia,Sherri Rankin,Yogesh Dhungana,Hongbo Chi

DOI: https://doi.org/10.1038/s41586-023-06299-8

IF: 64.8

2023-07-06

Nature

Abstract:Cancer cells evade T cell-mediated killing through tumour–immune interactions whose mechanisms are not well understood 1,2 . Dendritic cells (DCs), especially type-1 conventional DCs (cDC1s), mediate T cell priming and therapeutic efficacy against tumours 3 . DC functions are orchestrated by pattern recognition receptors 3,4,5 , although other signals involved remain incompletely defined. Nutrients are emerging mediators of adaptive immunity 6,7,8 , but whether nutrients affect DC function or communication between innate and adaptive immune cells is largely unresolved. Here we establish glutamine as an intercellular metabolic checkpoint that dictates tumour–cDC1 crosstalk and licenses cDC1 function in activating cytotoxic T cells. Intratumoral glutamine supplementation inhibits tumour growth by augmenting cDC1-mediated CD8 + T cell immunity, and overcomes therapeutic resistance to checkpoint blockade and T cell-mediated immunotherapies. Mechanistically, tumour cells and cDC1s compete for glutamine uptake via the transporter SLC38A2 to tune anti-tumour immunity. Nutrient screening and integrative analyses show that glutamine is the dominant amino acid in promoting cDC1 function. Further, glutamine signalling via FLCN impinges on TFEB function. Loss of FLCN in DCs selectively impairs cDC1 function in vivo in a TFEB-dependent manner and phenocopies SLC38A2 deficiency by eliminating the anti-tumour therapeutic effect of glutamine supplementation. Our findings establish glutamine-mediated intercellular metabolic crosstalk between tumour cells and cDC1s that underpins tumour immune evasion, and reveal glutamine acquisition and signalling in cDC1s as limiting events for DC activation and putative targets for cancer treatment.

multidisciplinary sciences
The Role of Cystine/Glutamate Antiporter SLC7A11/xCT in the Pathophysiology of Cancer

Nidhi Jyotsana,Kenny T. Ta,Kathleen E. DelGiorno

DOI: https://doi.org/10.3389/fonc.2022.858462

IF: 4.7

2022-02-23

Frontiers in Oncology

Abstract:SLC7A11/xCT is an antiporter that mediates the uptake of extracellular cystine in exchange for glutamate. Cystine is reduced to cysteine, which is a rate-limiting precursor in glutathione synthesis; a process that protects cells from oxidative stress and is, therefore, critical to cell growth, proliferation, and metabolism. SLC7A11 is expressed in different tissues and plays diverse functional roles in the pathophysiology of various diseases, including cancer, by regulating the processes of redox homeostasis, metabolic flexibility/nutrient dependency, immune system function, and ferroptosis. SLC7A11 expression is associated with poor prognosis and drug resistance in cancer and, therefore, represents an important therapeutic target. In this review, we discuss the molecular functions of SLC7A11 in normal versus diseased tissues, with a special focus on how it regulates gastrointestinal cancers. Further, we summarize current therapeutic strategies targeting SLC7A11 as well as novel avenues for treatment.

oncology
Complement Promotes Gvhd Through Suppressing Autophagy in Recipient Dendritic Cells after Allogeneic Hematopoietic Cell Transplantation in Mice

Hung D. Nguyen,David Bastian,Sandeepkumar Kuril,Mohammmed Dany,David Fairlie,Carl Atkinson,Besim Ogretmen,Stephen Tomlinson,Xue-Zhong Yu

DOI: https://doi.org/10.1182/blood.v130.suppl_1.1904.1904

IF: 20.3

2017-01-01

Blood

Abstract:Graft-versus-host disease (GVHD) limits the success of allogeneic hematopoietic stem cell transplantation (allo-HCT). Traditional therapies have targeted T cells, yet immunostimulatory dendritic cells (DCs) are critical in the pathogenesis of GVHD. Autophagy is a self-degradative process for cytosolic components and is required for maintaining homeostasis after allo-HCT. Complement receptors C3aR/C5aR can regulate immune responses by translating information gathered by complement fluid phase sensors into cellular responses. C3aR/C5aR have been reported to activate the autophagy inhibitor mTOR in cells. While depletion of autophagy in recipient DCs aggravates GVHD severity, and enhancing autophagy represents as a promising approach for treating immunological diseases, it is not known how escalation of autophagy regulates DC-functionality in GVHD pathogenesis. In the current study, we found that deficiency of C3aR/C5aR signaling significantly upregulated mTOR-independent autophagy in DCs (Figure 1B), which is associated with increased apoptosis, and reduced activation and antigen presenting capacity of C3aR/C5aR-/-DCs (Figure 1, A-C).
Gut dendritic cell activation links an altered colonic microbiome to mucosal and systemic T-cell activation in untreated HIV-1 infection

S M Dillon,E J Lee,C V Kotter,G L Austin,S Gianella,B Siewe,D M Smith,A L Landay,M C McManus,C E Robertson,D N Frank,M D McCarter,C C Wilson

DOI: https://doi.org/10.1038/mi.2015.33

IF: 9.02

2015-04-29

Mucosal Immunology

Abstract:HIV-1-associated disruption of intestinal homeostasis is a major factor contributing to chronic immune activation and inflammation. Dendritic cells (DCs) are crucial in maintaining intestinal homeostasis, but the impact of HIV-1 infection on intestinal DC number and function has not been extensively studied. We compared the frequency and activation/maturation status of colonic myeloid DC (mDC) subsets (CD1c+ and CD1cneg) and plasmacytoid DCs in untreated HIV-1-infected subjects with uninfected controls. Colonic mDCs in HIV-1-infected subjects had increased CD40 but decreased CD83 expression, and CD40 expression on CD1c+ mDCs positively correlated with mucosal HIV-1 viral load, with mucosal and systemic cytokine production, and with frequencies of activated colon and blood T cells. Percentage of CD83+CD1c+ mDCs negatively correlated with frequencies of interferon-γ-producing colon CD4+ and CD8+ T cells. CD40 expression on CD1c+ mDCs positively associated with abundance of high prevalence mucosal Prevotella copri and Prevotella stercorea but negatively associated with a number of low prevalence mucosal species, including Rumminococcus bromii. CD1c+ mDC cytokine production was greater in response to in vitro stimulation with Prevotella species relative to R. bromii. These findings suggest that, during HIV infection, colonic mDCs become activated upon exposure to mucosal pathobiont bacteria leading to mucosal and systemic immune activation.

immunology
Glutathione Synthesis Primes Monocytes Metabolic and Epigenetic Pathway for Β-Glucan-trained Immunity

Haibo Su,Jiaxin Huang,Shufeng Weng,Baoying Zhang,Tianran Zhang,Ying Xu

DOI: https://doi.org/10.1016/j.redox.2021.102206

IF: 11.4

2021-01-01

Redox Biology

Abstract:Trained monocytes and macrophages produce reactive oxygen species (ROS), which trigger antioxidative glutathione (GSH) response to buffer the rising ROS. However, whether and how the trained immunity is shaped by GSH synthesis remains unknown. Here, we report that β-glucan-trained macrophages from mice harboring a myeloid-specific deletion of the catalytic subunit of glutamate-cysteine ligase (Gclc) showed impaired GSH synthesis and decreased proinflammatory cytokine production in response to lipopolysaccharide challenge. Gclc deficiency compromised the activation of mammalian target of rapamycin-1 (mTOR) and expression of c-Myc transcription factors, abrogating the energy utilization and the metabolic reprogramming that allows β-glucan-trained macrophages to switch to glycolysis and glutaminolysis. Furthermore, Gclc deletion repressed effective H3K27me3 demethylation in the promoters of immunometabolic genes, such as Gls, Hk2, and Glut1, in β-glucan-trained macrophages by promoting the methyltransferase enhancer of zeste homolog 2 (EZH2). In vivo, myeloid-specific ablation of Gclc decreased the secretion of proinflammatory cytokines upon rechallenge with Candida albicans and these animals were less protected against the infection, compared with control littermates. Moreover, pharmacological inhibition of EZH2 enhanced the trained immunity response against Candida infection in Gclc-deficient mouse and human peripheral blood mononuclear cells treated with GCLC inhibitor buthionine sulfoximine (BSO). Thus, antioxidative GSH synthesis supports an environment conducive to β-glucan-induced metabolic and epigenetic reprogramming in trained immunity, allowing exploration of its functional consequences in autoimmune or inflammatory disease.
Characterising plasmacytoid and myeloid AXL + SIGLEC-6 + dendritic cell functions and their interactions with HIV

Freja A. Warner van Dijk,Orion Tong,Thomas R. O’Neil,Kirstie M. Bertram,Kevin Hu,Heeva Baharlou,Erica E. Vine,Kate Jenns,Martijn P. Gosselink,James W. Toh,Tim Papadopoulos,Laith Barnouti,Gregory J. Jenkins,Gavin Sandercoe,Muzlifah Haniffa,Kerrie J. Sandgren,Andrew N. Harman,Anthony L. Cunningham,Najla Nasr

DOI: https://doi.org/10.1371/journal.ppat.1012351

IF: 7.464

2024-06-27

PLoS Pathogens

Abstract:AXL + Siglec-6 + dendritic cells (ASDC) are novel myeloid DCs which can be subdivided into CD11c + and CD123 + expressing subsets. We showed for the first time that these two ASDC subsets are present in inflamed human anogenital tissues where HIV transmission occurs. Their presence in inflamed tissues was supported by single cell RNA analysis of public databases of such tissues including psoriasis diseased skin and colorectal cancer. Almost all previous studies have examined ASDCs as a combined population. Our data revealed that the two ASDC subsets differ markedly in their functions when compared with each other and to pDCs. Relative to their cell functions, both subsets of blood ASDCs but not pDCs expressed co-stimulatory and maturation markers which were more prevalent on CD11c + ASDCs, thus inducing more T cell proliferation and activation than their CD123 + counterparts. There was also a significant polarisation of naïve T cells by both ASDC subsets toward Th2, Th9, Th22, Th17 and Treg but less toward a Th1 phenotype. Furthermore, we investigated the expression of chemokine receptors that facilitate ASDCs and pDCs migration from blood to inflamed tissues, their HIV binding receptors, and their interactions with HIV and CD4 T cells. For HIV infection, within 2 hours of HIV exposure, CD11c + ASDCs showed a trend in more viral transfer to T cells than CD123 + ASDCs and pDCs for first phase transfer. However, for second phase transfer, CD123 + ASDCs showed a trend in transferring more HIV than CD11c + ASDCs and there was no viral transfer from pDCs. As anogenital inflammation is a prerequisite for HIV transmission, strategies to inhibit ASDC recruitment into inflamed tissues and their ability to transmit HIV to CD4 T cells should be considered. This study highlights the significance of AXL + Siglec-6 + dendritic cells (ASDC) in HIV transmission, particularly in inflamed peripheral tissues such as anogenital tissues, where HIV transmission is prevalent. It reveals that ASDCs are present in inflamed human tissues, including psoriasis affected skin, colorectal cancer and anogenital tissues. However, they are absent in uninflamed tissues. Furthermore, we investigated the expression of chemokine receptors that facilitate ASDC migration from blood to inflamed tissues, and their interactions with HIV and CD4 T cells. Notably, different subsets of ASDCs exhibit different expression levels of HIV binding receptors and showed trends of different phases of HIV transmission to T cells. Understanding ASDC involvement in HIV transmission could provide valuable insights for developing strategies to inhibit their recruitment to inflamed tissues and their ability to transmit the virus to CD4 T cells, potentially offering new avenues for HIV prevention and treatment.

microbiology,virology,parasitology
Selective Suicide of Cross-Presenting CD8+ Dendritic Cells by Cytochrome C Injection Shows Functional Heterogeneity Within This Subset.

Ming Lee Lin,Yifan Zhan,Anna I. Projetto,Sandro Prato,Li Wu,William R. Heath,Jose A. Villadangos,Andrew M. Lew

DOI: https://doi.org/10.1073/pnas.0712394105

2008-01-01

Abstract:Cross-presentation as a fundamental pathway of activating CD8(+) T cells has been well established. So far the application of this concept in vivo is limited, and the mechanisms that specialize CD8(+) dendritic cells (DCs) for this task are not fully understood. Here we take advantage of the specific cytosolic export feature of cross-presenting DCs together with the property of cytosolic cytochrome c (cyt c) in initiating Apaf-1-dependent apoptosis selectively in cross-presenting DCs. A single i.v. injection of cyt c in B6 mice produced a 2- to 3-fold reduction in splenic CD8(+) DCs but not in Apaf-1-deficient mice. Functional studies both in vivo and in vitro showed that cyt c profoundly abrogated OVA-specific CD8(+) T cell proliferation through its apoptosis-inducing effect on cross-presenting DCs. More importantly, in vivo injection of cyt c abolished the induction of cytotoxic T lymphocytes to exogenous antigen and reduced subsequent immunity to tumor challenge. In addition, only a proportion of CD8(+) DCs that express abundant IL-12 and Toll-like receptor 3 were efficient cross-presenters. Our data support the hypothesis that cross-presentation in vivo requires cytosolic diversion of endocytosed proteins, conferring cross-presentation specialization to a proportion of CD8(+) DCs. We propose that DCs incapable of such transfer, even within the CD8(+) DC subset, are unable to cross-present. Our model opens an avenue to specifically target cross-presenting DCs in vivo for manipulating cytotoxic T lymphocyte responses toward infections, tumors, and transplants.
High expression of antioxidant proteins in dendritic cells: possible implications in atherosclerosis

Aymeric Rivollier,Laure Perrin-Cocon,Sylvie Luche,Hélène Diemer,Jean-Marc Strub,Daniel Hanau,Alain van Dorsselaer,Vincent Lotteau,Chantal Rabourdin-Combe,Thierry Rabilloud,Christine Servet-Delprat

DOI: https://doi.org/10.48550/arXiv.q-bio/0611082

IF: 4.31

2006-11-24

Genomics

Abstract:Dendritic cells (DCs) display the unique ability to activate naive T cells and to initiate primary T cell responses revealed in DC-T cell alloreactions. DCs frequently operate under stress conditions. Oxidative stress enhances the production of inflammatory cytokines by DCs. We performed a proteomic analysis to see which major changes occur, at the protein expression level, during DC differentiation and maturation. Comparative two-dimensional gel analysis of the monocyte, immature DC, and mature DC stages was performed. Manganese superoxide dismutase (Mn-SOD) reached 0.7% of the gel-displayed proteins at the mature DC stage. This important amount of Mn-SOD is a primary antioxidant defense system against superoxide radicals, but its product, H(2)O(2), is also deleterious for cells. Peroxiredoxin (Prx) enzymes play an important role in eliminating such peroxide. Prx1 expression level continuously increased during DC differentiation and maturation, whereas Prx6 continuously decreased, and Prx2 peaked at the immature DC stage. As a consequence, DCs were more resistant than monocytes to apoptosis induced by high amounts of oxidized low density lipoproteins containing toxic organic peroxides and hydrogen peroxide. Furthermore DC-stimulated T cells produced high levels of receptor activator of nuclear factor kappaB ligand, a chemotactic and survival factor for monocytes and DCs. This study provides insights into the original ability of DCs to express very high levels of antioxidant enzymes such as Mn-SOD and Prx1, to detoxify oxidized low density lipoproteins, and to induce high levels of receptor activator of nuclear factor kappaB ligand by the T cells they activate and further emphasizes the role that DCs might play in atherosclerosis, a pathology recognized as a chronic inflammatory disorder.
Cystine deprivation triggers CD36-mediated ferroptosis and dysfunction of tumor infiltrating CD8 + T cells

Chenfeng Han,Minmin Ge,Pengfei Xing,Tian Xia,Cangang Zhang,Kaili Ma,Yifu Ma,Shicheng Li,Wenhui Li,Xiaowei Liu,Baojun Zhang,Liyuan Zhang,Lianjun Zhang

DOI: https://doi.org/10.1038/s41419-024-06503-1

2024-02-15

Cell Death and Disease

Abstract:Cancer cells develop multiple strategies to evade T cell-mediated killing. On one hand, cancer cells may preferentially rely on certain amino acids for rapid growth and metastasis. On the other hand, sufficient nutrient availability and uptake are necessary for mounting an effective T cell anti-tumor response in the tumor microenvironment (TME). Here we demonstrate that tumor cells outcompete T cells for cystine uptake due to high Slc7a11 expression. This competition induces T-cell exhaustion and ferroptosis, characterized by diminished memory formation and cytokine secretion, increased PD-1 and TIM-3 expression, as well as intracellular oxidative stress and lipid-peroxide accumulation. Importantly, either Slc7a11 deletion in tumor cells or intratumoral cystine supplementation improves T cell anti-tumor immunity. Mechanistically, cystine deprivation in T cells disrupts glutathione synthesis, but promotes CD36 mediated lipid uptake due to dysregulated cystine/glutamate exchange. Moreover, enforced expression of glutamate-cysteine ligase catalytic subunit (Gclc) promotes glutathione synthesis and prevents CD36 upregulation, thus boosting T cell anti-tumor immunity. Our findings reveal cystine as an intracellular metabolic checkpoint that orchestrates T-cell survival and differentiation, and highlight Gclc as a potential therapeutic target for enhancing T cell anti-tumor function.

cell biology
Dectin-1 Stimulation Promotes a Distinct Inflammatory Signature in the Setting of HIV-infection and Aging

Archit Kumar,Jiawei Wang,Allen Esterly,Chris Radcliffe,Haowen Zhou,Brent Vander Wyk,Heather G. Allore,Sui Tsang,Lydia Barakat,Subhasis Mohanty,Hongyu Zhao,Albert C. Shaw,Heidi J. Zapata

DOI: https://doi.org/10.1101/2022.09.01.505710

2022-01-01

bioRxiv

Abstract:Dectin-1 is an innate immune receptor that recognizes and binds β-1,3/1,6 glucans on fungi. We evaluated Dectin-1 function in myeloid cells in a cohort of HIV-positive and HIV-negative young and older adults. Stimulation of monocytes with β-D-glucans induced a pro-inflammatory phenotype in monocytes of HIV-infected individuals that was characterized by increased levels of IL-12, TNF-α, and IL-6, with some age-associated cytokine increases also noted. Dendritic cells showed a striking HIV-associated increase in IFN-α production. These increases in cytokine production paralleled increases in Dectin-1 surface expression in both monocytes and dendritic cells that were noted with both HIV and aging. Differential gene expression analysis showed that HIV-positive older adults had a distinct gene signature compared to other cohorts characterized by a robust TNF-α and coagulation response (increased at baseline), a persistent IFN-α and IFN-γ response, and an activated dendritic cell signature/M1 macrophage signature upon Dectin-1 stimulation. Dectin-1 stimulation induced a strong upregulation of MTORC1 signaling in all cohorts, although increased in the HIV-Older cohort (stimulation and baseline). Overall, our study demonstrates that the HIV Aging population has a distinct immune signature in response to Dectin-1 stimulation. This signature may contribute to the pro-inflammatory environment that is associated with HIV and Aging.
492. Dectin-1 Stimulation Promotes a Distinct Inflammatory Signature in the Setting of Aging and HIV-infection

Heidi Zapata,Archit Kumar,Jiawei Wang,Albert Shaw,Haowen Zhou,Christopher Radcliffe,Lydia A Barakat,Brent Vander Wyk,Heather Allore,Hongyu Zhao,Sui Tsang,Data Manager,Subhasis Mohanty

DOI: https://doi.org/10.1093/ofid/ofac492.550

2022-01-01

Open Forum Infectious Diseases

Abstract:Abstract Background Dectin-1 is an innate immune pattern recognition receptor that recognizes and binds b-1,3/1,6 glucans on fungal pathogens. Methods We evaluated Dectin-1 function in innate immune cells (Monocytes and Dendritic cells) in a cohort of HIV-positive and HIV-negative young and older adults (n= 81). PBMCs were stimulated with whole glucan particles (1,3/1,6-b-glucan, WGP), a specific Dectin-1 agonist and analyzed via intracellular cytokine staining (ICS) and multicolor flow cytometry of monocytes and dendritic cells. Sorted CD14+ CD16+ monocytes stimulated with WGP and subjected to RNA-seq analysis. Results Stimulation of monocytes with β-D-glucans induced a pro-inflammatory phenotype in monocytes of HIV-infected individuals that was characterized by increased levels of IL-12, TNF-a, and IL-6, with some age-associated cytokine increases also noted. Dendritic cells showed a striking HIV-associated increase in IFN-a production. This increase in cytokine production paralleled increases in Dectin-1 surface expression in both monocytes and dendritic cells that were noted with both HIV and aging. Differential gene expression analysis showed that HIV-positive older adults had a distinct gene signature compared to other cohorts characterized by a robust TNF-a and coagulation response that was already increased at baseline, and a persistent IFN-α and IFN-γ response. HIV-older adults also demonstrated an activated dendritic cell signature and M1 macrophage signature upon stimulation that was not seen in young individuals. Pathways upregulated in all cohorts were the signaling pathways MTORC-1, hypoxia pathway (pathways involved in trained immunity) and the unfolded protein response. Of note MTORC-1 signaling was upregulated at baseline in HIV-Older adults. Conclusion Overall, our study demonstrates that increased age and HIV-infection can affect the function of Dectin-1 and lead to a distinct inflammatory signature. Dectin-1 stimulation in HIV-Older adults led to a more pro-inflammatory phenotype that was demonstrated through both protein and gene expression. Dectin-1 induced inflammation in HIV-infected individuals may be contributing to the pro-inflammatory environment that is seen in the setting of both aging and HIV-infection. Disclosures All Authors: No reported disclosures.
Systemic Inhibition of Myeloid Dendritic Cells by Circulating HLA Class I Molecules in HIV-1 Infection

Jinghe Huang,Maha Al-Mozaini,Jerome Rogich,Mary F Carrington,Katherine Seiss,Florencia Pereyra,Mathias Lichterfeld,Xu G Yu

DOI: https://doi.org/10.1186/1742-4690-9-11

2012-01-01

Retrovirology

Abstract:BACKGROUND:HIV-1 infection is associated with profound dysfunction of myeloid dendritic cells, for reasons that remain ill-defined. Soluble HLA class I molecules can have important inhibitory effects on T cells and NK cells, but may also contribute to reduced functional properties of professional antigen-presenting cells. Here, we investigated the expression of soluble HLA class I isoforms during HIV-1 infection and assessed their functional impact on antigen-presenting characteristics of dendritic cells.RESULTS:Soluble HLA class I molecules were highly upregulated in progressive HIV-1 infection as determined by quantitative Western blots. This was associated with strong increases of intracellular expression of HLA class I isoforms in dendritic cells and monocytes. Using mixed lymphocyte reactions, we found that soluble HLA class I molecules effectively inhibited the antigen-presenting properties of dendritic cells, however, there was no significant influence of HLA class I molecules on the cytokine-secretion properties of these cells. The immunomodulatory effects of soluble HLA class I molecules were mediated by interactions with inhibitory myelomonocytic MHC class I receptors from the Leukocyte Immunoglobulin Like Receptor (LILR) family.CONCLUSIONS:During progressive HIV-1 infection, soluble HLA class I molecules can contribute to systemic immune dysfunction by inhibiting the antigen-presenting properties of myeloid dendritic cells through interactions with inhibitory myelomonocytic HLA class I receptors.
Influence of the serotonin transporter promoter gene and shyness on children's cerebral responses to facial expressions.

M. Battaglia,A. Ogliari,A. Zanoni,A. Citterio,U. Pozzoli,R. Giorda,C. Maffei,C. Marino

DOI: https://doi.org/10.1001/ARCHPSYC.62.1.85

Archives of General Psychiatry

Abstract:BACKGROUND Childhood shyness can predate social anxiety disorder and may be associated with biased discrimination of facial expressions of emotions. OBJECTIVE To determine whether childhood shyness, or the serotonin transporter promoter polymorphism genotype, can predict participants' visual event-related potentials in response to expressions of children of similar ages. DESIGN Study group drawn from an inception cohort of 149 subjects characterized 1 year before the present study by their degree of shyness. SETTING Third- and fourth-grade schoolchildren. PARTICIPANTS Forty-nine of the inception cohort children, randomly selected. MAIN OUTCOME MEASURES Latencies and amplitudes of the N400 waveform in response to happy, neutral, and angry expressions. RESULTS Shyness predicted significantly smaller N400 amplitudes in response to anger (at Pz: P < or = .04) and to a neutral expression (at Pz: P < or = .047). Shyness was significantly different across the 3 genotypes, the SS genotype being associated with higher shyness levels (analysis of variance: F(2,42) = 4.47, P < or = .02; Tukey honestly significant difference, SS vs LL, P < or = .01). An analysis of covariance showed that neither the type of expression nor the genotype per se influenced the N400 amplitudes, but a significant expression X genotype interaction was found (F(4,72) = 3.57, P < or = .01), sustained by the difference in amplitude of the SS and S carrier subjects compared with the LL subjects when exposed to the anger expression (Tukey honestly significant difference, P < or = .02). CONCLUSION Children who manifest higher levels of shyness or have 1 or 2 copies of the short allele of the serotonin transporter promoter gene appear to have a different pattern of processing affective stimuli of interpersonal hostility.
Complement C3a and C5a Receptors Promote GVHD by Suppressing Mitophagy in Recipient Dendritic Cells.

Hung Nguyen,Sandeepkumar Kuril,David Bastian,Jisun Kim,Mengmeng Zhang,Silvia G. Vaena,Mohammed Dany,Min Dai,Jessica Lauren Heinrichs,Anusara Daenthanasanmak,Supinya Iamsawat,Steven Schutt,Jianing Fu,Yongxia Wu,David P. Fairlie,Carl Atkinson,Besim Ogretmen,Stephen Tomlinson,Xue-Zhong Yu

DOI: https://doi.org/10.1172/jci.insight.121697

IF: 9.4958

2018-01-01

JCI Insight

Abstract:Graft-versus-host disease (GVHD) is a major complication of allogeneic hematopoietic cell transplantation (HCT). DCs play critical roles in GVHD induction. Modulating autophagy represents a promising therapeutic strategy for the treatment of immunological diseases. Complement receptors C3aR/C5aR expressed on DCs regulate immune responses by translating extracellular signals into intracellular activity. In the current study, we found that C3aR/C5aR deficiency enhanced ceramide-dependent lethal mitophagy (CDLM) in DCs. Cotransfer of host-type C3aR-/-/C5aR-/- DCs in the recipients significantly improved GVHD outcome after allogeneic HCT, primarily through enhancing CDLM in DCs. C3aR/C5aR deficiency in the host hematopoietic compartment significantly reduced GVHD severity via impairing Th1 differentiation and donor T cell glycolytic activity while enhancing Treg generation. Prophylactic treatment with C3aR/C5aR antagonists effectively alleviated GVHD while maintaining the graft-versus-leukemia (GVL) effect. Altogether, we demonstrate that inhibiting C3aR/C5aR induces lethal mitophagy in DCs, which represents a potential therapeutic approach to control GVHD while preserving the GVL effect.
Glutathione Induced Immune-Stimulatory Activity by Promoting M1-Like Macrophages Polarization via Potential ROS Scavenging Capacity

Da Hye Kwon,Hyesook Lee,Cheol Park,Su-Hyun Hong,Sang Hoon Hong,Gi-Young Kim,Hee-Jae Cha,Suhkmann Kim,Heui-Soo Kim,Hye-Jin Hwang,Yung Hyun Choi

DOI: https://doi.org/10.3390/antiox8090413

IF: 7.675

2019-09-18

Antioxidants

Abstract:The present study investigated the immunomodulatory activity of reduced glutathione (GSH) by assessment of the macrophage polarization (MP)-mediated immune response in RAW 264.7 cells. Furthermore, we identified the signal pathway associated with immune regulation by GSH. The expressions of MP-associated cytokines and chemokines were assessed using cytokine array, nCounter Sprit platform, ELISA and immunoblotting. Phagocytosis activity and intracellular reactive oxygen species (ROS) generation were measured using fluorescence-activated cell sorter. As results of the cytokine array and nCounter gene array, GSH not only up-regulated pro-inflammatory cytokines, including interleukins and tumor necrosis factor-α, but also overexpressed neutrophil-attracting chemokines. Furthermore, GSH significantly stimulated the production of immune mediators, including nitric oxide and PGE2, as well as phagocytosis activity through nuclear factor kappa B activation. In addition, GSH significantly decreased LPS-induced ROS generation, which was associated with an activation of nuclear factor erythroid-derived 2-related factor 2 (Nrf2)/ heme oxygenease-1 (HO-1) signaling pathway. Our results suggest that GSH has potential ROS scavenging capacity via the induction of Nrf2-mediated HO-1, and immune-enhancing activity by regulation of M1-like macrophage polarization, indicating that GSH may be a useful strategy to increase the human defense system.

biochemistry & molecular biology,chemistry, medicinal,food science & technology

[Alcoholism and depression: catecholamines and brain-derived neurotrophic factors].

Role of solute carrier transporters in regulating dendritic cell maturation and function

The Role of Glutathione in the Management of Cell-Mediated Immune Responses in Individuals with HIV

Glutathione synthesis is compromised in erythrocytes from individuals with HIV

Host genetics contributes to the effectiveness of dendritic cell-based HIV immunotherapy

Cystine/Glutamate Antiporter in Schizophrenia: From Molecular Mechanism to Novel Biomarker and Treatment

SLC38A2 and glutamine signalling in cDC1s dictate anti-tumour immunity

The Role of Cystine/Glutamate Antiporter SLC7A11/xCT in the Pathophysiology of Cancer

Complement Promotes Gvhd Through Suppressing Autophagy in Recipient Dendritic Cells after Allogeneic Hematopoietic Cell Transplantation in Mice

Gut dendritic cell activation links an altered colonic microbiome to mucosal and systemic T-cell activation in untreated HIV-1 infection

Glutathione Synthesis Primes Monocytes Metabolic and Epigenetic Pathway for Β-Glucan-trained Immunity

Characterising plasmacytoid and myeloid AXL + SIGLEC-6 + dendritic cell functions and their interactions with HIV

Selective Suicide of Cross-Presenting CD8+ Dendritic Cells by Cytochrome C Injection Shows Functional Heterogeneity Within This Subset.

High expression of antioxidant proteins in dendritic cells: possible implications in atherosclerosis

Cystine deprivation triggers CD36-mediated ferroptosis and dysfunction of tumor infiltrating CD8 + T cells

Dectin-1 Stimulation Promotes a Distinct Inflammatory Signature in the Setting of HIV-infection and Aging

492. Dectin-1 Stimulation Promotes a Distinct Inflammatory Signature in the Setting of Aging and HIV-infection

Systemic Inhibition of Myeloid Dendritic Cells by Circulating HLA Class I Molecules in HIV-1 Infection

Influence of the serotonin transporter promoter gene and shyness on children's cerebral responses to facial expressions.

Complement C3a and C5a Receptors Promote GVHD by Suppressing Mitophagy in Recipient Dendritic Cells.

Glutathione Induced Immune-Stimulatory Activity by Promoting M1-Like Macrophages Polarization via Potential ROS Scavenging Capacity